Fujirebio Europe NV - Strategic SWOT Analysis Review

July 2021 | 26 pages | ID: F981DF1BF7BEN
GlobalData

Abstracts

Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Fujirebio Europe NV (Fujirebio Europe), a subsidiary of Fujirebio Inc, designs, develops and produces in vitro diagnostic (IVD) testing solutions and markets them worldwide. Its diagnostic products consist of Innotest products for ELISA; INNO-LIA products for autoimmune diseases; INNO-LiPA products for line probe assay; INNO-BIA products for bead-based multiparameter immunoassay, and Lumipulse products for chemiluminescent enzyme immunoassay (CLEIA) system, among others. The company products find application in the treatment of infectious diseases, cancer, genetic testing, thyroid, fertility, tissue typing, neurodegeneration and bones. The company markets its products through its subsidiaries and distributors worldwide. Fujirebio Europe is headquartered in Gent, Belgium.

Fujirebio Europe NV Key Recent Developments

Dec 08,2020: OHMX.bio and Fujirebio Europe receive grant of 720K EURO

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Fujirebio Europe NV - Key Facts
Fujirebio Europe NV - Key Employees
Fujirebio Europe NV - Major Products and Services
Fujirebio Europe NV - History
Fujirebio Europe NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Fujirebio Europe NV - Business Description
Fujirebio Europe NV - Corporate Strategy
Fujirebio Europe NV - SWOT Analysis
SWOT Analysis - Overview
Fujirebio Europe NV - Strengths
Fujirebio Europe NV - Weaknesses
Fujirebio Europe NV - Opportunities
Fujirebio Europe NV - Threats
Fujirebio Europe NV - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Fujirebio Europe NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fujirebio Europe NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Fujirebio Europe NV, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Dec 08, 2020: OHMX.bio and Fujirebio Europe receive grant of 720K EURO

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Fujirebio Europe NV, Key Facts
Fujirebio Europe NV, Key Employees
Fujirebio Europe NV, Major Products and Services
Fujirebio Europe NV, History
Fujirebio Europe NV, Subsidiaries
Fujirebio Europe NV, Key Competitors
Fujirebio Europe NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fujirebio Europe NV, Medical Equipment, Deals By Type, 2015 to YTD 2021
Fujirebio Europe NV, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Fujirebio Europe NV, Medical Equipment, Deals By Year, 2015 to YTD 2021
Fujirebio Europe NV, Medical Equipment, Deals by Type, 2015 to YTD 2021